176 related articles for article (PubMed ID: 28665163)
1. What's new in treatment of pancreatic cancer: a patent review (2010-2017).
Ramos MC; Boulaiz H; Griñan-Lison C; Marchal JA; Vicente F
Expert Opin Ther Pat; 2017 Nov; 27(11):1251-1266. PubMed ID: 28665163
[TBL] [Abstract][Full Text] [Related]
2. What's new in the diagnosis of pancreatic cancer: a patent review (2011-present).
Boulaiz H; Ramos MC; Griñán-Lisón C; García-Rubiño ME; Vicente F; Marchal JA
Expert Opin Ther Pat; 2017 Dec; 27(12):1319-1328. PubMed ID: 28929814
[TBL] [Abstract][Full Text] [Related]
3. Emerging protein kinase inhibitors for treating pancreatic cancer.
Furuse J; Nagashima F
Expert Opin Emerg Drugs; 2017 Mar; 22(1):77-86. PubMed ID: 28253828
[TBL] [Abstract][Full Text] [Related]
4. Novel antifungal agents: a patent review (2011 - present).
Castelli MV; Butassi E; Monteiro MC; Svetaz LA; Vicente F; Zacchino SA
Expert Opin Ther Pat; 2014 Mar; 24(3):323-38. PubMed ID: 24392809
[TBL] [Abstract][Full Text] [Related]
5. Selective induction of apoptosis: promising therapy in pancreatic cancer.
Liu Z; Li D; Zheng X; Wang E; Wang J
Curr Pharm Des; 2013; 19(12):2259-68. PubMed ID: 23082976
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of new drugs for pancreatic cancer.
Sugarman R; Patel R; Sharma S; Plenker D; Tuveson D; Saif MW
Expert Opin Drug Metab Toxicol; 2019 Jul; 15(7):541-552. PubMed ID: 31241371
[No Abstract] [Full Text] [Related]
7. The role of pancreatic and duodenal homeobox 1 as a therapeutic target in pancreatic cancer.
Fendrich V; Lauth M
Expert Opin Ther Targets; 2014 Nov; 18(11):1277-83. PubMed ID: 25078025
[TBL] [Abstract][Full Text] [Related]
8. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
9. Emerging cell-cycle inhibitors for pancreatic cancer therapy.
Bayraktar S; Rocha Lima CM
Expert Opin Emerg Drugs; 2012 Dec; 17(4):571-82. PubMed ID: 23126234
[TBL] [Abstract][Full Text] [Related]
10. Emerging patents in the therapeutic areas of glioma and glioblastoma.
Harris M; Svensson F; Kopanitsa L; Ladds G; Bailey D
Expert Opin Ther Pat; 2018 Jul; 28(7):573-590. PubMed ID: 29950117
[TBL] [Abstract][Full Text] [Related]
11. Are sigma modulators an effective opportunity for cancer treatment? A patent overview (1996-2016).
Collina S; Bignardi E; Rui M; Rossi D; Gaggeri R; Zamagni A; Cortesi M; Tesei A
Expert Opin Ther Pat; 2017 May; 27(5):565-578. PubMed ID: 28051882
[TBL] [Abstract][Full Text] [Related]
12. Quinazoline derivatives as anticancer drugs: a patent review (2011 - present).
Ravez S; Castillo-Aguilera O; Depreux P; Goossens L
Expert Opin Ther Pat; 2015 Jul; 25(7):789-804. PubMed ID: 25910402
[TBL] [Abstract][Full Text] [Related]
13. Analysis of patents on anti-rheumatoid arthritis therapies issued in China.
Yuan HY; Zhang XL; Zhang XH; Meng L; Wei JF
Expert Opin Ther Pat; 2015; 25(8):909-30. PubMed ID: 26066366
[TBL] [Abstract][Full Text] [Related]
14. Advances in treatment of pulmonary arterial hypertension: patent review.
Vaidya B; Pangallo M; Ruffenach G; Cunningham CM; Perron JC; Kolluru S; Eghbali M; Gupta V
Expert Opin Ther Pat; 2017 Aug; 27(8):907-918. PubMed ID: 28355094
[TBL] [Abstract][Full Text] [Related]
15. Drugs in preclinical and early-stage clinical development for pancreatic cancer.
Asuthkar S; Rao JS; Gondi CS
Expert Opin Investig Drugs; 2012 Feb; 21(2):143-52. PubMed ID: 22217246
[TBL] [Abstract][Full Text] [Related]
16. Quinazoline derivatives as potential anticancer agents: a patent review (2007 - 2010).
Marzaro G; Guiotto A; Chilin A
Expert Opin Ther Pat; 2012 Mar; 22(3):223-52. PubMed ID: 22404097
[TBL] [Abstract][Full Text] [Related]
17. MEK inhibitors in oncology: a patent review (2015-Present).
Mahapatra DK; Asati V; Bharti SK
Expert Opin Ther Pat; 2017 Aug; 27(8):887-906. PubMed ID: 28594589
[TBL] [Abstract][Full Text] [Related]
18. Current and Future Therapies for Advanced Gastric Cancer.
Davidson M; Okines AF; Starling N
Clin Colorectal Cancer; 2015 Dec; 14(4):239-50. PubMed ID: 26524924
[TBL] [Abstract][Full Text] [Related]
19. [Current aspects of chemotherapy of metastatic pancreatic and biliary tract carcinomas].
Bokemeyer C; Kollmannsberger C; Oettle H; Kanz L
Praxis (Bern 1994); 2000 Sep; 89(39):1545-52. PubMed ID: 11068508
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of JAK2 and JAK3: an update on the patent literature 2010 - 2012.
Dymock BW; See CS
Expert Opin Ther Pat; 2013 Apr; 23(4):449-501. PubMed ID: 23367873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]